Australia · Delayed Price · Currency is AUD CONNEQT Health Company Description
CONNEQT Health Limited engages in the design, manufacture, and marketing of medical devices used in cardiovascular health management in the Americas, Europe, and the Asia Pacific.
It offers SphygmoCor, a vascular biometric technology that captures central hemodynamics and arterial stiffness for noninvasive measurement of vascular biomarkers including central aortic pressures and arterial stiffness indices.
The company also provides medical devices and vascular biomarkers for hypertension, cardiovascular disease, and other vascular health disorders; and develops and sells medical devices, digital solutions, and wearables, home health, decentralized clinical trials, and remote patient monitoring.
It sells its cardiovascular devices and services to hospitals, clinics, research institutions, and pharmaceutical companies.
The company was formerly known as CardieX Limited and changed its name to CONNEQT Health Limited in September 2025.
CONNEQT Health Limited was founded in 1994 and is based in Sydney, Australia.
| Country | Australia |
| Founded | 1994 |
| Industry | Electromedical and Electrotherapeutic Apparatus |
| CEO | Craig Cooper |
Contact Details
Address: 55 Lime Street Sydney, 2000 Australia | |
| Phone | 61 2 9874 8761 |
| Website | conneqthealth.com |
Stock Details
| Ticker Symbol | CQT |
| Exchange | Australian Securities Exchange |
| Fiscal Year | July - June |
| Reporting Currency | AUD |
| SIC Code | 3845 |
Key Executives
| Name | Position |
|---|---|
| Craig R. Cooper BEC, L.L.B. | Co-Founder, Group Chief Executive Officer, MD and Executive Director |
| Niall Charles Edgar Cairns ACA, B.Ec, FAICD | Co-Founder and Executive Chairman |
| Dr. Ahmad Qasem Ph.D. | Chief Science and Research Officer |
| Douglas T. Kurschinski | Executive Vice President and Head of Global Sales for AtCor Medical Division |
| Catherine Liao | Chief Strategy Officer |
| Dr. Sanjeev Bhavnani | Chief Clinical Officer |
| Louisa Ho | Company Secretary |